The carotenoid halocynthiaxanthin: A novel inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2
- 1 February 1992
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 293 (1) , 208-212
- https://doi.org/10.1016/0003-9861(92)90386-b
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Molecular Targets for AIDS TherapyScience, 1990
- The antiviral activity of dideoxycytidineJournal of Antimicrobial Chemotherapy, 1989
- Interaction between rifabutin and human immunodeficiency virus type 1: inhibition of replication, cytopathic effect, and reverse transcriptase in vitroAntimicrobial Agents and Chemotherapy, 1988
- AzidothymidineThe Journal of Infectious Diseases, 1988
- Genome organization and transactivation of the human immunodeficiency virus type 2Nature, 1987
- Suramin in the treatment of AIDS: Mechanism of actionAntiviral Research, 1987
- PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1986
- Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T‐cell lymphotropic virus (HTLV‐III)/lymphadenopathy‐associated virus (LAV)International Journal of Cancer, 1986
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986
- Inhibition of HTLV-III/LAV replication by foscarnetBiochemical Pharmacology, 1985